PMA device
Roadsaver/CASPER Carotid Stent Device
MicroVention, Inc. · Stent, Carotid (NIM, Class III) · First FDA decision Nov 20, 2024, newest Jun 23, 2025Carotid artery disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
0
Naming "Roadsaver CASPER"
MAUDE reports
0
Brand "Roadsaver CASPER", since 2015
PubMed studies
3
Mentioning "Roadsaver CASPER"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Roadsaver/CASPER Carotid Stent Device
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Roadsaver/CASPER Carotid Stent DevicePMA supplement
P210030-S001 · Decided Jun 23, 2025 · 140 days after receipt · Normal 180 Day Track No User Fee
Device type: Stent, carotid (NIM) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R8Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R7Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R6Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R3Updated Sep 21, 2026
- Carotid Artery Stenting in Post-Approval StudiesNational analysisReview closedCAG-00259NUpdated Sep 17, 2026
- Carotid Artery StentingNational analysisReview closedCAG-00085RUpdated Sep 17, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Roadsaver CASPER", any status and sponsor, newest update first.
No registered device study names "Roadsaver CASPER".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Roadsaver CASPER", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NIM
2,799 reports: 1,699 malfunction, 994 injury, 98 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Roadsaver CASPER"[tiab]. The summary above synthesizes these.
- Contemporary Results of Carotid Artery Stenting Using Low-Profile Dual-Metal Layer Nitinol Micromesh Stents in Relation to Single-Layer Carotid Stents.
Kahlberg A, Bilman V, Ardita V, et al. · J Endovasc Ther · 2021
- Carotid Artery Stenting With Double-Layer Stent: A Systematic Review and Meta-Analysis.
Pini R, Faggioli G, Paraskevas KI, et al. · J Endovasc Ther · 2024Systematic Review, Meta-Analysis
- One swallow does not a summer make but many swallows do: accumulating clinical evidence for nearly-eliminated peri-procedural and 30-day complications with mesh-covered stents transforms the carotid revascularisation field.
Musiaek P, Hopkins LN, Siddiqui AH · Postepy Kardiol Interwencyjnej · 2017Review
Other devices of this type
Also filed under product code NIM.
- XACT® Carotid Stent SystemAbbott Vascular, Inc. · PMA 2025
- ENROUTE Transcarotid Stent SystemBoston Scientific Corporation · PMA 2023
- Rx Acculink Carotid Stent SystemAbbott Vascular · PMA 2016
- Carotid Wallstent Monorail EndoprosthesisBoston Scientific Corp · PMA 2024
- Acculink Carotid Stent System and Rx Acculink Carotid Stent SystemAbbott Vascular · PMA 2017
- Cartoid Wallstent Monorail EndoprosthesisBoston Scientific Corp · PMA 2012
- Protege Gps & Protege Rx Carotid Stent SystemsMedtronic Vascular, Inc. · PMA 2011
- Cordis Precise Nitinol StentCordis US Corporation · PMA 2008
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.